Inventor · disambiguated record
Olaf Panknin
Also filed as: PANKNIN OLAF
16 granted patents·10 pending applications·36 citations·filing 2013–2024
90Inventor score
Top patents by PatentIndex Score
26 records- 0193US12478696B2Gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2024·Granted Nov 25, 2025·1 cites·14 claims
- 0291US11491245B2Gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2020·Granted Nov 8, 2022·2 cites·12 claims
- 0388US10722601B2Gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2018·Granted Jul 28, 2020·2 cites·16 claims
- 0488US9957235B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted May 1, 2018·8 cites·34 claims
- 0586US10179123B22-aryl- and 2-arylalkyl-benzimidazoles as mIDH1 inhibitorsBayer Pharma AG·Filed 2016·Granted Jan 15, 2019·4 cites·15 claims
- 0686US9951027B2Benzimidazol-2-amines as MIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted Apr 24, 2018·8 cites·22 claims
- 0784US10137209B2Gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2016·Granted Nov 27, 2018·2 cites·13 claims
- 0879US10137110B21-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumorsBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·4 cites·29 claims
- 0979US2023113481A1New gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2022·Application pending·0 cites
- 1076US10975060B2High relaxivity gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2017·Granted Apr 13, 2021·1 cites·13 claims
- 1175US10370339B2N-Methylbenzimidazoles as mIDH1 inhibitorsBayer Pharma AG·Filed 2016·Granted Aug 6, 2019·2 cites·15 claims
- 1269US10414734B25-hydroxyalkylbenzimidazoles as mIDH1 inhibitorsBayer Pharma AG·Filed 2016·Granted Sep 17, 2019·1 cites·16 claims
- 1368US11427578B1Substituted pyrrolopyridine-derivativesBayer Pharma AG·Filed 2018·Granted Aug 30, 2022·1 cites·18 claims
- 1465US11814369B2High relaxivity gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2021·Granted Nov 14, 2023·0 cites·11 claims
- 1562US11311520B2Substituted dihydroimidazopyridinediones as MKNK1 and MKNK2 inhibitorsBayer Pharma AG·Filed 2020·Granted Apr 26, 2022·0 cites·7 claims
- 1658US2024228469A1Pcsk9 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 1757US2024182431A1New contrast agent for use in magnetic resonance imagingBAYER AG·Filed 2022·Application pending·0 cites
- 1855US2024239767A1Pcsk9 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 1954US2024217951A1Pcsk9 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 2053US2024239804A1Furoindazole derivatives as antagonists or inhibitors of gpr84BAYER AG·Filed 2022·Application pending·0 cites
- 2151US10442772B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2018·Granted Oct 15, 2019·0 cites·21 claims
- 2251US2024417407A1Furoindazole derivatives as gpr84 antagonistsBAYER AG·Filed 2022·Application pending·0 cites
- 2351US2019350910A1Substituted dihydroimidazopyridinediones as mknk1 and mknk2 inhibitorsBayer Pharma AG·Filed 2018·Application pending·0 cites
- 2440US2014357655A1Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonistsBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 2539US10919862B2Fused imidazoles as mIDH1 inhibitorsBayer Pharma AG·Filed 2016·Granted Feb 16, 2021·0 cites·25 claims
- 2639US2016052936A1Spiroindoline derivatives for use as gonadotropin-releasing hormone receptor antagonistsBayer Pharma AG·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Olaf Panknin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →